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To the Editor
Many adverse cardiac effects have been reported follow-
ing energy drinks consumption, among which atrial
arrhythmias, acute coronary syndromes, and even cardiac
arrest. These can develop also in the absence of other
symptoms related to acute toxicity, such as neurological
symptoms. Considering the absence of specific toxico-
logical tests, the diagnosis of energy drink intoxication
still remains clinical.
We report three cases of tachyarrhythmia from atrial
fibrillation in young and healthy study participants
following a large intake of energy drinks.
Three young male patients, aged 23, 22, and 26 years,
were evaluated for a symptomatic episode of atrial fibril-
lation occurring in the early hours of the morning
(between 6 : 00 and 10 : 00 a.m.). All reported arrhythmic
palpitations and ECG showed atrial fibrillation with high
ventricular response (135–170 bpm mean frequency). In
all these patients, a thorough anamnesis disclosed an
abundant ingestion of energy drinks within the 8 h prior
to the onset of arrhythmia. No other clinical sign was
present; in particular, the common toxicological analyses
were negative, as were routine laboratory tests.
The cardiac arrhythmia disappeared spontaneously in a
short period of time and the follow-up, lasting 2 years in
abstinence from energy drinks, was negative.
Retrospectively, we could estimate the total amount of
caffeine ingested: it was 125 mg in two patients and up to
80 mg in the third where alcohol intake was associated.
The second patient also referred a psychological situation
of stress.
We can identify a triad, on which our diagnosis was based:
recent abundant consumption of energy drinks, atrial
fibrillation with a spontaneous rapid return to a sinus1558-2027  2016 Italian Federation of Cardiology. All rights reserved.
© 2016 Italian Federation of Carhythm, absence of other important clinical signs and
of abnormalities in the routine laboratory, and toxicologi-
cal tests.
From a pathophysiological point of view, we can observe
that the sole high content of caffeine does not explicate
the particular toxicity of energy drinks, which can be
referred also to a synergic action of alcohol or of other
substances contained in energy drinks, such as taurine,
guaranà, ginseng, ginkgo biloba, L-carnitine, glucoronate,
B vitamins, etc. Toxicology of these substances is still
incomplete;1 their action can be enhanced by a condition
of psychological stress.
Atrial fibrillation or acute peak of arterial hypertension
after energy drink overconsumption can be considered
benign complications,2–7 whereas in the presence of
other conditions such as acute long QT syndrome or
angina, they can become more complicated.8–14 In the
case of pre-existing, often unknown, cardiac diseases,
such as channelopathies or latent coronary insufficiency,
energy drink abuse can be followed by deleterious
consequences, such as cardiac arrest or even death from
acute coronary syndromes. This latter risk can be
augmented by the energy drinks’ detrimental effects
on platelets and endothelial function with secondary
hypercoagulability.15,16
The dangers of energy drink overconsumption must
be considered in the general medical practice sphere.17
In addition to the diagnostic procedure of acute cardiac
events of unknown origin, an exogenous agent, including
also energy drink overconsumption, can be suspected.
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To the Editor
International guidelines recommend the utilization of
multidisciplinary teams to guide the management of
patients undergoing percutaneous cardiac procedures.
However, the functioning and composition of such a
‘Heart Team’ vary across and within countries. In the
present letter, it is mainly referred to transcatheter aortic
valve implantation (TAVI)/replacement, but all consider-
ations can be extended to the whole spectrum of inter-
ventional cardiovascular procedures.
After the age of 80, the incidence of dementia is high
(http://www.alzheimer-europe.org/Research/European-
Collaboration-on-Dementia/Prevalence-of-dementia/Pr
evalence-of-dementia-in-Europe). The ‘Heart Teams’,
which are devoted to the evaluation of candidates for
various devices, are not supposed to take into account© 2016 Italian Federation of Cpatients’ cognitive function. For instance, the mean
reported age of patients undergoing TAVI is more than
80 years in all registries.1,2 Among those recipient
patients around 30% could supposedly be affected by
dementia symptoms. Can we really be unaware of this
problem? Are we really happy as physicians and sons/
daughters, and tomorrow’s patients, to maintain an effi-
cient heart in parallel with an inefficient brain? Or
should we introduce a more objective way to evaluate
the whole health status in our patients? The following
points should be taken into consideration:(1) Pardreintervention mental capabilities of patients aged
80þ years should be fully investigated. Geriatric
syndromes, together with frailty, which are fre-
quently seen in elderly patients and remain import-
ant preoperative risk factors, are often not included in
surgical risk scores, although frailty is significantly
related to functional decline and prognosis. Most
geriatricians can accurately identify a frail patient.
Therefore, a geriatrician and a neurologist with
special skills in the management of frailty and
cognitive disorders would be welcome in the ‘Heart
Team’.(2) Cultural/skill bias in the presently formed ‘Heart
Teams’ is not unfrequently encountered. The
clinical cardiologist of the team is usually the referent
of the patient. Therefore, he/she, by referring the
patient, is originally inclined toward intervention. An
independent clinical cardiologist should be included.
The other members of the team are usually an
interventional cardiologist and a cardiac surgeon:
their role in the debate is usually confined to who is
going to do the procedure. The imaging specialist just
provides the technical information to the former two.
Therefore, once the patient case is sent to the
judgment of the actual ‘Heart Team’, the patient will
anyway receive some kind of interventional treat-
ment.3(3) Apart from the potential trivial gain of the
procedure itself in some cases, in some others it
could also be rather counterproductive. It has been
previously indicated that cognitive functions could
be further impaired by procedures like TAVI.
Stroke is reported in 3.3 1.8% of patients within
30 days and increasing up to 5.2 3.4% 3.3 1.8%
the first year after TAVI.4 Procedural transcranial
Doppler ultrasound has been shown to detect
embolic signals in a sizeable proportion of patients
undergoing TAVI and postprocedure ischaemic
brain lesions on MRI are detected in up to 77%
of patients.5 Despite technical advancements such
as filter protection of the cerebral vessel takeoff,
that has been shown to significantly reduce the
occurrence of these complications,6 the chance of
iatrogenically making worse a preexisting neuro-
logical condition is not remote.iology. All rights reserved.
904 Journal of Cardiovascular Medicine 2016, Vol 17 No 12(4) The prevalence of aortic stenosis is up to 7% of the
population past the age of 757 and valve replacement
is the only treatment that improves survival and
quality of life.8 However, the increased availability of
transcatheter options for the management of valvular
heart disease has increased the assessment of people
with life-limiting conditions for whom treatment may
not be an option. Despite the fact that it may appear
as an oxymoron, prolongation of life may not
necessarily represent a valuable target in many
patients for whom prolonged survival could rather
be contraindicated for objective and subjective
reasons. Despite palliative care not being considered
central in cardiac care, and cardiac patients receive
proportionately fewer palliative care services, the
integration of best palliative care practices in
transcatheter valve disease management programmes
could establish a gold standard of programme
development, to ensure that patients for whom
intervention is not an option do not experience the
negative outcome of their eligibility assessment as
loss of hope, abandonment, and increased uncer-
tainty.9Ideally, in opposition to the present trend of friendly
agreement, very often encountered in Heart Teams, a
team producing real dialectical confrontation between
members, based on the needs of scrutinized patients,
should be implemented. Such a team should comprise
the patient’s primary cardiologist, a cardiac surgeon, an
interventional cardiologist, an imaging specialists, a heart
failure/valve disease specialist, a cardiac anaesthesiolo-
gist, a nurse practitioner, and a rehabilitation/geriatrician
specialists (eight individuals).10 Unfortunately, ‘Heart
Teams’ are rarely formed as such.11,12 Keeping in mind
organizational difficulties, a less crowded and similarly
balanced ‘Heart Team’ could be formed by only four
members, with two members culturally biased toward
interventions (interventional cardiologist and cardiac sur-
geon) and two members with opposite attitudes bias
(clinical cardiologist/heart valve specialist and geriatri-
cian/neurologist). To avoid bias, members of the team
should rotate by drawing lots. Cases of disagreement
should be resolved by consensus.
Apart from the potential futility of some interventions,
especially in the very old patients, it is important to
underline the fact that rising healthcare costs cannot
be sustained by public and private insurances over the
long term and therefore a careful evaluation of priorities,© 2016 Italian Federation of Caagreed by patients, doctors, health authorities, and repre-
sentatives, should be undertaken. It is not possible to
guarantee everything for everybody and specific choices
have to be made. In the recent past, some hard choices in
the oncological setting have been made and are still
fiercely debated. However, specific choices should be
made in all medical fields and the axiom ‘we can do this,
therefore we do it’ should not replace more thoughtful
clinical decisions. Despite a ‘Heart Team’ approach not
being without multiple potential problems, its imple-
mentation has become mandatory and its composition
should always reflect the most relevant professional skills
on a peer-to-peer basis for better patient and resources
management.
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